Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil PK/PD in Children With OSA
NCT03958396Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2015
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of remifentanil in pain (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Change in end-expired carbon dioxide from baseline over time, Change in respiratory rate from baseline over time and 2 more. Started Sep 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT03958396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958396.